Risk and impact of delayed renal impairment in patients with locally advanced head and neck squamous cell carcinoma receiving chemoradiotherapy with cisplatin.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Thana PatimarattanananNuttapong Ngamphaiboon

Abstract

An incidence of cisplatin-induced acute kidney injury (AKI) of 34% has been reported in patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC). However, delayed cisplatin-induced nephrotoxicity and long-term renal outcomes remain poorly studied. Patients with LA-HNSCC who underwent definitive or postoperative cisplatin-based chemoradiotherapy (CRT) were included. Acute kidney disease (AKD) was defined as newly developed estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m2 for < 3 months, ≥ 35% decrease in eGFR, or > 50% increase in serum creatinine for <3 months from baseline. A total of 509 patients were analyzed. AKD and AKI occurred in 27.9% and 13.4% of patients, respectively. Most patients had primary prophylactic feeding tube (95%) and definitive CRT (83%). More AKD patients had an ECOG status of 0 (p = 0.017), diabetes (p = 0.044), and hypertension (p < 0.001). AKI, but not AKD, was significantly associated with cumulative cisplatin dose, delay, dose reduction, termination, and hospitalization during CRT. GFR percentage in patients with AKD declined significantly during CRT (- 36%), worsened at 3 months (- 39%), and had not recovered to baseline at 12 months after CRT (- 29%). Multivar...Continue Reading

References

Aug 1, 1978·The American Journal of Medicine·N E Madias, J T Harrington
Sep 1, 1986·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M Lam, D J Adelstein
Jan 1, 1995·Toxicology and Applied Pharmacology·Y K KimS H Lee
Jan 1, 1994·American Journal of Nephrology·G BrilletC Jacobs
Jul 1, 1993·American Journal of Hypertension·E RitzM Siebels
Aug 2, 2002·American Journal of Clinical Oncology·Lequn CaoDavid Sumoza
Jun 5, 2003·Expert Opinion on Pharmacotherapy·Jörg Thomas Hartmann, Hans-Peter Lipp
Jan 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Athanassios ArgirisArlene A Forastiere
Aug 16, 2006·Annals of Internal Medicine·Andrew S LeveyUNKNOWN Chronic Kidney Disease Epidemiology Collaboration
Apr 26, 2007·The Pharmacogenomics Journal·L RiedemannA am Zehnhoff-Dinnesen
Apr 15, 2008·Current Opinion in Nephrology and Hypertension·Gary S Hill
Jun 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mitchell MachtayK Kian Ang
Mar 21, 2009·Current Opinion in Nephrology and Hypertension·Bruce A Perkins, Andrzej S Krolewski
May 19, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Jean-Pierre PignonUNKNOWN MACH-NC Collaborative Group
Jul 25, 2009·Clinical Pharmacology and Therapeutics·K K FilipskiA Sparreboom
Nov 10, 2011·Toxins·Ronald P MillerWilliam Brian Reeves
Jan 22, 2015·Electrolyte & Blood Pressure : E & BP·Gi-Su OhHong-Seob So
Feb 7, 2016·International Journal of Surgery Case Reports·Tomohiko SasakiYoshihiro Minamiya
Apr 14, 2016·Clinical Journal of the American Society of Nephrology : CJASN·Sheron LatchaCarlos D Flombaum
Sep 28, 2016·Critical Care : the Official Journal of the Critical Care Forum·Marlies Ostermann, Michael Joannidis
Mar 23, 2017·Head & Neck·Ricardo Ribeiro GamaGeoffrey Liu
Apr 26, 2017·The Oncologist·Daniel J CronaMatthew I Milowsky
Jan 11, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shveta S MotwaniGary C Curhan
Oct 12, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Matthew R TrendowskiM Eileen Dolan
Sep 5, 2019·Current Opinion in Critical Care·Mark A Perazella

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.